Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GW201
- Development stage
- Unknown
- Lead developer
- Beijing Greatway Pharmaceutical Technology
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
GW201 is a small molecule drug candidate developed by Beijing Greatway Pharmaceutical Technology. It is currently in Phase 1 clinical trials, primarily being investigated for the treatment of depressive disorder and ischemic stroke. The drug is administered orally as a tablet, and early studies are focused on evaluating its safety, tolerability, and pharmacokinetics in healthy subjects. There are also references to research involving Gateway Biotechnology (USA) developing a tinnitus therapy under the code name GW-201 based on tetrandrine—a compound isolated from Stephania tetrandra—targeting inflammatory and calcium signaling pathways; however, the Chinese development program appears distinct and does not specify tetrandrine as the active ingredient[1][2][3]. The precise mechanism of action for Beijing Greatway's GW201 has not been disclosed.
- Other names
- GW-201GW201GW 201
Beyond the preview
Go deeper on GW201.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GW201.